Inhalers for chronic obstructive pulmonary disease (COPD) are a mainstay of treatment. These medications are inhaled through your mouth so they can directly reach your lungs. If your healthcare ...

Medically reviewed by Lindsay Cook, PharmDMedically reviewed by Lindsay Cook, PharmD Inhalers for chronic obstructive pulmonary disease (COPD) are a mainstay of treatment. These medications are ...

Mylan has become the first company to launch a generic version of GlaxoSmithKline's (GSK) big-selling respiratory drug Seretide in the UK. Seretide (salmeterol xinafoate/fluticasone propionate ...

New reports reveal the most commonly prescribed inhaler in the U.S. may actually be contributing to climate change. While these inhalers are critically important to saving lives and making it ...

Inhalers and nebulizers are devices that deliver medicine directly into the lungs. The difference between the two devices is in the way they deliver the medication. An inhaler relies on pressure, ...

A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers. Developed by Australian medtech firm ...

The TechSilen Tinnitus Inhaler has emerged as a promising contender, thanks to its unique formulation and fast-acting relief properties. In this comprehensive review, we will delve into the ...

CMS is expected to announce in early 2025 the list of up to 15 Medicare Part D drugs that will be subject to price negotiations in 2025, with negotiated prices expected to be implemented in 2027.

Excessive use of reliever inhalers for asthma is linked to a significantly increased risk of dying from the disease, a new study revealed today. Researchers found that over-use of short acting ...

Sub-optimally controlled asthma is common, in part because of normalisation of symptoms, underuse of preventer therapy, overuse of reliever therapy, and poor inhaler technique. Ensuring patients are ...

The tobacco giant that makes Marlboro cigarettes has sold a UK inhaler company for a knock-down price due to what it calls an "unwarranted" backlash. Philip Morris International (PMI) has ...